Introducing Letrozole, the generic for Femara, Anti‑Breast Cancer Tablet – a nonsteroidal aromatase inhibitor that reduces estrogen synthesis. It effectively lowers circulating estrogen levels to inhibit hormone‑dependent tumor growth. Experience improved disease management, reduced recurrence risk, and enhanced quality of life with consistent, targeted hormonal suppression in postmenopausal breast cancer patients.